The Learning Portal will be under maintenance Saturday, 8 August between 6 AM and 6 PM EST. Portal functionality will be unavailable during this window.
We apologize for any inconvenience caused during this time.

RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
Regulatory Focus™ > News Articles > In Focus: Compliance and Start-ups

In Focus: Compliance and Start-ups

Posted 01 May 2010 | By

Start-up companies and others in the early phases of drug, biologic and device development face a variety of issues and pitfalls. In addition to obtaining financing, these firms need an effective strategy and tactics to get from one milestone to the next. During this process, the company must, of course, follow the rules and regulations associated with bringing the product to market.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe